Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients-Reference-Cited by-同舟云学术

Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients

Published:2014-03-27 Issue:1 Volume:145 Page:91-100
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lee Hyo Sang,Ko Beom Seok,Ahn Sei Hyun,Son Byung Ho,Lee Jong Won,Kim Hee Jeong,Yu Jong Han,Kim Sung-Bae,Jung Kyung Hae,Ahn Jin-Hee,Cha Joo Hee,Kim Hak Hee,Lee Hee Jin,Song In-Hye,Gong Gyungyub,Park Seol-Hoon,Lee Jong Jin,Moon Dae Hyuk

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-2920-z.pdf

Reference30 articles.

1. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30:96–102

2. Balu-Maestro C, Chapellier C, Bleuse A, Chanalet I, Chauvel C, Largillier R (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72(2):145–152

3. Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM (2001) MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with X-ray mammography and palpation. J Magn Reson Imaging 13(6):868–875. doi: 10.1002/jmri.1124

4. Segara D, Krop IE, Garber JE, Winer E, Harris L, Bellon JR, Birdwell R, Lester S, Lipsitz S, Iglehart JD, Golshan M (2007) Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96(6):474–480. doi: 10.1002/jso.20856

5. Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, Mirza AN, Ames FC, Babiera GV, Feig BW, Hunt KK, Kuerer HM, Meric-Bernstam F, Ross MI, Singletary SE (2006) Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243(2):257–264. doi: 10.1097/01.sla.0000197714.14318.6f00000658-200602000-00016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Breast Imaging and Positron Emission Mammography;PET Clinics;2023-10

2. ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

3. SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicated γ-Cameras;J NUCL MED TECHNOL;2022

4. SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicatedγ-Cameras;Journal of Nuclear Medicine Technology;2022-06

5. Competing and alternative techniques to breast MRI;Advances in Magnetic Resonance Technology and Applications;2022